Arcutis Biotherapeutics

YTD

ALL

Trade Arcutis Biotherapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ARQT

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis.

CEO

Todd Franklin Watanabe

CEOTodd Franklin Watanabe

Employees

342

Employees342

Headquarters

Westlake Village, California

HeadquartersWestlake Village, California

Founded

2016

Founded2016

Employees

342

Employees342

ARQT Key Statistics

Market cap

1.55B

Market cap1.55B

Price-Earnings ratio

-12.50

Price-Earnings ratio-12.50

Dividend yield

—

Dividend yield—

Average volume

2.01M

Average volume2.01M

High today

$13.59

High today$13.59

Low today

$12.83

Low today$12.83

Open price

$13.55

Open price$13.55

Volume

3.32M

Volume3.32M

52 Week high

$17.75

52 Week high$17.75

52 Week low

$6.99

52 Week low$6.99

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own ARQT. This list is generated using Robinhood data, and it’s not a recommendation.

Credo Technology Group